SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-20-000013
Filing Date
2020-03-09
Accepted
2020-03-09 16:05:45
Documents
14
Period of Report
2020-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K anab3920208k.htm   iXBRL 8-K 35313
  Complete submission text file 0001370053-20-000013.txt   181181

Data Files

Seq Description Document Type Size
2 EXHIBIT 101.SCH anab-20200306.xsd EX-101.SCH 4451
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20200306_cal.xml EX-101.CAL 624
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20200306_def.xml EX-101.DEF 1474
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20200306_lab.xml EX-101.LAB 27263
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20200306_pre.xml EX-101.PRE 14114
8 EXTRACTED XBRL INSTANCE DOCUMENT anab3920208k_htm.xml XML 4385
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 20698002
SIC: 2834 Pharmaceutical Preparations